
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Cholinesterase is an enzyme that catalyzes the hydrolysis of choline-based esters, notably acetylcholine, a critical neurotransmitter. This breakdown is essential for allowing cholinergic neurons to return to their resting state, enabling normal muscle relaxation and nerve signal transmission.

Reported Benefits (Provisional)
Origin & History

Cholinesterase is a key enzyme that hydrolyzes acetylcholine and other choline esters, terminating synaptic transmission at cholinergic synapses. Two main types exist: acetylcholinesterase (AChE), primarily found at neuromuscular junctions and in the brain, and butyrylcholinesterase (BChE), primarily found in the liver and plasma. These enzymes are essential for the precise regulation of neurotransmission and neuromuscular control, impacting cognitive function and muscle relaxation.
Research Narrative (Provisional)
Cholinesterase is extensively researched in neuroscience, pharmacology, and toxicology. Its activity is a key biomarker in neurodegenerative conditions and exposure to organophosphate pesticides. Clinical trials show that AChE inhibitors like donepezil and rivastigmine improve symptoms of cognitive decline.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Hydrolyzes acetylcholine and butyrylcholine into choline and acetic acid. - Dependent on active sites containing serine for catalytic function. - Influences acetylcholine recycling and neural responsiveness.
Reported Mechanism (Provisional)
Two main types of cholinesterase exist: acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). AChE is responsible for rapidly hydrolyzing acetylcholine in cholinergic synapses, terminating synaptic transmission and allowing neurons to reset. BChE, while also breaking down acetylcholine, primarily metabolizes ester drugs like aspirin and antidepressants, as well as pesticides and organophosphates.
Clinical Narrative (Provisional)
Cholinesterase activity is a crucial biomarker in various neurological and toxicological studies, particularly in neurodegenerative diseases like Alzheimer's and Parkinson's. Clinical trials have demonstrated that acetylcholinesterase inhibitors (AChEIs), such as donepezil and rivastigmine, effectively improve cognitive symptoms in patients with mild to moderate Alzheimer's disease. These studies typically involve double-blind, placebo-controlled designs with varied sample sizes, showing modest but significant improvements in memory, attention, and overall cognitive function.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







